EP3592741
NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS
:
EP einkaleyfi: Þýðing ekki lögð inn:
6.3.2018:
15.2.2023:
18711703.1
:
5.3.2038
:
NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS
6.3.2018
15.2.2023
:
Pfizer Inc.:
235 East 42nd Street, New York, NY 10017, US
:
BRODNEY, Michael Aaron:
Newton, Massachusetts 02461, US
:
CHAPPIE, Thomas Allen:
Carlisle, Massachusetts 01741, US
:
CHEN, Jinshan Michael:
Madison, Connecticut 06443, US
:
COE, Jotham Wadsworth:
Niantic, Connecticut 06357, US
:
COFFMAN, Karen Jean:
Pawcatuck, Connecticut 06379, US
:
GALATSIS, Paul:
Newton, Massachusetts 02465, US
:
GARNSEY, Michelle Renee:
Providence, Rhode Island 02906, US
:
HELAL, Christopher John:
Mystic, Connecticut 06355, US
:
HENDERSON, Jaclyn Louise:
Cambridge, Massachusetts 02139, US
:
KORMOS, Bethany Lyn:
Somerville, Massachusetts 02143, US
:
KURUMBAIL, Ravi G.:
East Lyme, Connecticut 06333, US
:
MARTINEZ-ALSINA, Luis Angel:
Gales Ferry, Connecticut 06335, US
:
PETTERSSON, Martin Youngjin:
Littleton, Massachusetts 01460, US
:
REESE, Matthew Richard:
Mystic, Connecticut 06355, US
:
ROSE, Colin Richard:
Quaker Hill, Connecticut 06375, US
:
STEPAN, Antonia Friederike:
4103 Bottmingen, CH
:
VERHOEST, Patrick Robert:
Newton, Massachusetts 02460, US
:
WAGER, Travis T.:
Brookline, Massachusetts 02445-6804, US
:
WARMUS, Joseph Scott:
Ledyard, Connecticut 06339, US
:
ZHANG, Yuan:
East Lyme, Connecticut 06333, US
:
201762469756 P:
10.3.2017:
US
:
201862629152 P:
12.2.2018:
US
:
IB2018051439:
6.3.2018
:
C07D 471/04, C07D 519/00, A61K 31/437, A61P 25/16, A61P 25/28, A61P 25/18